River Stone Biotech ApS: Financial statements 2019
CVR: 39126729
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
River Stone Biotech ApS (CVR 39126729) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 691,841 and a net result of DKK -14,329,089 compared with DKK -11,103,388 the year before. Equity in the 2019 report amounted to DKK 10,108,013. The solvency ratio was 80.1%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 691,841
- Profit/Loss
- DKK -14,329,089
- Equity
- DKK 10,108,013
- Total Assets
- DKK 12,617,241
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 692 t. | -14.3 mio. | 10.1 mio. | 13 |
| 2018 | - | - | -11.1 mio. | -11.1 mio. | 11 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
River Stone Biotech ApS has published its annual report for 2018. The net result was DKK -11,103,388.
As of February 6, 2019, Ri Magnoliavej 12 ApS has been appointed auditor of River Stone Biotech ApS.
As of February 6, 2019, EY Godkendt Revisionspartnerselskab has stepped down as auditor of River Stone Biotech ApS.
About River Stone Biotech ApS
River Stone Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jørgen Hansen. The board consists of Jørgen Hansen and Paul D. Goldenheim. The company is owned by River Stone Biotech Inc.. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK 1,169,131 and a net result of DKK -31,204,765 compared with DKK -44,572,973 the year before. Equity in the 2025 report amounted to DKK 7,827,761.